Johnson & Johnson is using AI to accelerate drug discovery efforts, saying the technology has cut the time needed to generate early-stage drug development leads by half. The company revealed that AI drug discovery tools are helping researchers...
The European Commission has approved Novartis Rhapsido (remibrutinib treatment) for adults suffering from chronic spontaneous urticaria (CSU treatment) who do not respond well to antihistamines. The European Commission approval gives patien...
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) to market Fingolimod Capsules 0.5 mg in the United States. The approval marks another important step in the company’s efforts to strength...
Jennifer Li, SVP, Head of APAC Sales, Medidata, engaged in a conversation with Thiruamuthan, Assistant Editor at India Pharma Outlook, discusses how AI is transforming clinical trials in India by accelerating patient recruitment, enhancing data
Indian drugmaker Cipla has received approval from the USFDA approval process for a generic respiratory inhaler used to treat breathing-related conditions. The approval strengthens the company’s growing presence in the U.S. pharmaceutical mark...
Novo Nordisk reported positive Phase 3 results today for its semaglutide pill, marking a key step toward expanding diabetes treatment for younger patients. The late-stage trial, known as PIONEER TEENS, tested the oral drug in children aged...
Merck has secured a key step forward as the Merck KEYTRUDA FDA priority review gains momentum in bladder cancer treatment. The US Food and Drug Administration has granted priority review for KEYTRUDA and KEYTRUDA QLEX, both evaluated in...
Morepen Laboratories Limited has once again strengthened its reputation for quality standards and regulatory compliance by clearing a USFDA inspection with nil adverse observations. This marks the fourth consecutive time that the company’s Masulak...
AstraZeneca said its experimental drug tozorakimab cuts COPD flare-ups in patients with chronic obstructive pulmonary disease (COPD) in a Phase III trial, meeting the study’s primary goal. The tozorakimab results showed a significant drop in...
In an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Ashish Vig, CEO, Cipla Digital Health & Leader (Ecommerce, Modern Trade, Organized Retail Pharmacies), discusses how digital health platforms are transforming India’s heal
, CDSCO.jpg)